Liu Lili – Trademark Portfolio
Entity Type: 01
Liu Lili owns a portfolio of 33 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as AJT, HEVID, JULOS, PEKVU, and ATROFY. Of these, 25 are registered and 2 are pending. The portfolio spans 13 Nice Classification classes, led by Class 21 (Housewares) and Class 20 (Furniture). Headquartered in Shenzhen, Guangdong.
Avenue, Longgang District,
10A, Building 3, Xijinhaoyuan, Fu'an
Shenzhen, Guangdong 518100 , CN
Showing of trademarks Trademarks
Trademark Classifications
Liu Lili's trademark portfolio spans 13 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Common metals and their alloys; metal building materials; transportable buildings of metal
Frequently Asked Questions
How many trademarks does Liu Lili have?
Liu Lili has 33 U.S. trademarks filed with the USPTO. Of these, 25 registered, 2 pending, 5 abandoned, 1 cancelled.
What trademark classes does Liu Lili file in?
Liu Lili files trademarks across 13 Nice Classification classes. The most active classes are Class 21 (Housewares), Class 20 (Furniture), Class 10 (Medical Apparatus), Class 25 (Clothing), Class 5 (Pharmaceuticals). Class 21 covers household or kitchen utensils and containers; combs and sponges; brushes.
What are Liu Lili's most well-known trademarks?
Liu Lili's registered trademark portfolio includes well-known marks such as AJT, HEVID, JULOS, PEKVU, and ATROFY. These are among 25 currently registered trademarks in the portfolio.
What is Liu Lili's trademark registration success rate?
Liu Lili has a 81% trademark registration rate, with 25 out of 31 resolved applications resulting in successful registration. Currently, 2 applications are pending review.